Authors
Latest:
Monitoring Treatment Response in Treat-to-Target in CDExperts continue the discussion on treat-to-target in CD, highlighting monitoring treatment response.
Latest:
Untapped Potentials - Exploring Overlooked Therapies for Type 2 DiabetesIn this episode of MEDcast, the expert panelists examine some underutilized therapies in type 2 diabetes (T2D) and explore their potential as effective treatment choices for many patients.
Latest:
Anticipated Developments in the Field of Plaque PsoriasisMatthew Brunner, MHS, PA-C, DFAAPA, highlights the most anticipated developments in the field of treating patients with plaque psoriasis.
Latest:
How New Therapies Change Discussions Around Screening, Management of MASHIn the final installment in our 5-part video series, our pair of experts in hepatology touch upon how an approval for MASH would impact conversations around screening for asymptomatic patient populations.
Latest:
Concluding ThoughtsA panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.
Latest:
Appropriate Guidance for CRC Screening Age, Role of Advocacy OrganizationsIn part 5 of our 5-part discussion, experts discuss their perspective on appropriate guidance for screening age and the future of CRC advocacy.
Latest:
Patient Subgroups With a Higher Prevalence of HypercortisolismThe panel emphasizes the importance of early identification of patients based on subgroups, such as those with difficult-to-control diabetes, hypertension, and bone issues, highlighting that the inability to lower a patient's insulin dosage is a significant risk factor for hypercortisolism.
Latest:
A Patient-Centric Medcast on The Journey Through Moderate Plaque PsoriasisAdvanced practice providers in dermatology discuss exciting developments in the treatment landscape of plaque psoriasis. Listen to their insights into the often-challenging journey patients go on. The arrival of novel oral systemic treatment options offers opportunities to alleviate the burden of this chronic disease.
Latest:
The Future and Resources in HCV CareExpert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.
Latest:
Clinical Trial Overview: DMEMatthew Cunningham, MD, FASRS, provides the highlights of the YOSEMITE and RHINE trials for patients with diabetic macular edema (DME).
Latest:
Advice for Dermatologists in Treating Psoriasis in Patients With Skin of ColorDr Linda Stein Gold, Dr Mona Shahriari and Dr Seemal Desai share advice for improving psoriasis care for patients with skin of color.
Latest:
Advice for Providers Treating VitiligoDr. Woolery-Lloyd shares her advice for vitiligo providers and tips for helpful communication with patients.
Latest:
Key Takeaways for Ulcerative Colitis ManagementExperts in gastroenterology share take-home messages for the management of ulcerative colitis.
Latest:
Optimizing the Management of TRDAn expert panel shares insight on the future treatment landscape for treatment-resistant depression.
Latest:
Brett Nowlan, MD: My Year Working During a PandemicA lipidologist from Connecticut describes his experience during the COVID-19 pandemic and explains why he sees getting the vaccine as his "biggest contribution" to healthcare during the pandemic.
Latest:
Final Thoughts on Treatment of AsthmaRaffi Tachdjian, MD, MPH, FAAAAI, FACAAI; Dareen D. Siri, MD, FAAAAI, FACAAI; Nicole Chase, MD, FAAP, FACAAI, FAAAAI; and Andrew White, MD, give final thoughts on asthma management, considering the current treatment landscape.
Latest:
Beyond Skin Deep: Validating and Transforming SD Patient CareDermatologists end their discussion on seborrheic dermatitis (SD), highlighting key takeaways for patients and clinicians on managing this condition.
Latest:
Key Takeaways for Lipid Lowering in Hypercholesterolemia and ASCVDDrs Erin Michos, Pam Taub, Robert Busch, Alison Bailey, and Jorge Plutzky offer key takeaways in the management of hypercholesterolemia and ASCVD.
Latest:
Qazi Corner, Edition 5: Tofacitinib, Fenofibrates, Pouchitis Guidelines and BLUE-CThe first quarterly issue of 2024 reviews a promising JAK inhibitor for acute severe ulcerative colitis, fenofibrates in PBC, new recommendations from the AGA, and a next generation multi-target DNA stool test for detecting colorectal cancer.
Latest:
Gout Isn’t a Punchline. It’s Time to Stop Treating it Like One.As an industry and a society, we must take gout more seriously. That effort begins with the physicians who diagnose and treat it.
Latest:
The PA Experience at ACLM 2021: Lettuce Discuss Benefits of Lifestyle MedicineLaura Ross, PA-C, details her experiences at the American College of Lifestyle Medicine conference and the role of lifestyle modification as a cornerstone of cardiovascular risk management.
Latest:
Advice for Sickle Cell Disease ManagementSophie M. Lanzkron, MD, MHS; Jeffrey D. Lebensburger; and John J. Strouse, MD, PhD, share key takeaways and closing thoughts for the management of sickle cell disease.
Latest:
Diabetes Dialogue: 2024 ACP Type 2 Diabetes RecommendationsIn this episode, hosts break down the latest type 2 diabetes recommendations from the American College of Physicians and offer their perspective on second-line therapies in T2D.
Latest:
The Important, Evolving Role of Pharmacists in Helping Patients Quit SmokingMore than two-thirds of smokers want to quit, but lack proper resources. A prescribing professional could help make up that difference.
Latest:
Optimizing RAASi Therapy for Cardiovascular, Renal Health, with Kam Kalantar-Zadeh, MD, MPH, PhDKam Kalantar-Zadeh, MD, MPH, PhD, discusses his presentation focusing on dietary challenges, potassium control, and potential solutions associated with RAASi therapy.
